Preskoči na vsebino

Neonatalna medicina

Prevention of Drug-Induced Anemia or Thrombocytopenia

Patent ductus arteriosus, low platelets, cyclooxygenase inhibitors, and intraventricular hemorrhage in very low birth weight preterm infants. (odpre novo okno)

Brunner B, Hoeck M, Schermer E, Streif W, Kiechl-Kohlendorfer U.

Vir‎: J Pediatr 2013;163(1):23-8.

Indeksirano‎: PubMed 23351600

DOI‎: 10.1016/j.jpeds.2012.12.035

https://www.ncbi.nlm.nih.gov/pubmed/23351600 (odpre novo okno)

Natalizumab use during the third trimester of pregnancy. (odpre novo okno)

Haghikia A, Langer-Gould A, Rellensmann G, Schneider H, Tenenbaum T, Elias-Hamp B, Menck S, Zimmermann J, Herbstritt S, Marziniak M, Kümpfel T, Meinl I, Plavina T, Gold R, Hellwig K.

Vir‎: JAMA Neurol 2014;71(7):891-5.

Indeksirano‎: PubMed 24821217

DOI‎: 10.1001/jamaneurol.2014.209

https://www.ncbi.nlm.nih.gov/pubmed/24821217 (odpre novo okno)

Hemolytic anemia and methemoglobinemia in a preterm baby as a complication of antenatal intraamnial injection of toluidine blue. (odpre novo okno)

Mehler K, Oberthuer A, Weisshaar G, Valter M, Vierzig A, Eifinger F.

Vir‎: Klin Padiatr 2013;225(5):263-5.

Indeksirano‎: PubMed 23519748

DOI‎: 10.1055/s-0033-1333756

https://www.ncbi.nlm.nih.gov/pubmed/23519748 (odpre novo okno)

Drug-induced thrombocytopenia in children. (odpre novo okno)

Reese JA, Nguyen LP, Buchanan GR, Curtis BR, Terrell DR, Vesely SK, George JN.

Vir‎: Pediatr Blood Cancer 2013;60(12):1975-81.

Indeksirano‎: PubMed 24038783

DOI‎: 10.1002/pbc.24682

https://www.ncbi.nlm.nih.gov/pubmed/24038783 (odpre novo okno)